Renaissance Technologies
SGMO

Renaissance Technologies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Renaissance Technologies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$947K Sell
3,836,665
-4,593,658
-54% -$1.83M ﹤0.01% 2302
2025
Q4 		$3.54M Sell
8,430,323
-1,752,140
-17% -$929K 0.01% 1534
2025
Q3 		$6.86M Buy
10,182,463
+3,343,029
+49% +$1.8M 0.01% 1306
2025
Q2 		$3.7M Buy
6,839,434
+3,671,327
+116% +$2.18M ﹤0.01% 1710
2025
Q1 		$2.08M Buy
3,168,107
+83,230
+3% +$88.1K ﹤0.01% 1967
2024
Q4 		$3.15M Sell
3,084,877
-1,767,900
-36% -$3.23M ﹤0.01% 1738
2024
Q3 		$4.2M Buy
4,852,777
+726,200
+18% +$532K 0.01% 1547
2024
Q2 		$1.48M Buy
4,126,577
+1,528,600
+59% +$826K ﹤0.01% 2077
2024
Q1 		$1.74M Sell
2,597,977
-547,901
-17% -$397K ﹤0.01% 2124
2023
Q4 		$1.71M Buy
3,145,878
+780,124
+33% +$360K ﹤0.01% 2049
2023
Q3 		$1.42M Sell
2,365,754
-701,742
-23% -$751K ﹤0.01% 2068
2023
Q2 		$3.99M Sell
3,067,496
-165,299
-5% -$226K 0.01% 1560
2023
Q1 		$5.69M Buy
3,232,795
+1,113,299
+53% +$3.18M 0.01% 1398
2022
Q4 		$6.66M Buy
2,119,496
+453,400
+27% +$1.76M 0.01% 1328
2022
Q3 		$8.16M Buy
1,666,096
+226,600
+16% +$1.16M 0.01% 1138
2022
Q2 		$5.96M Buy
1,439,496
+676,400
+89% +$2.93M 0.01% 1434
2022
Q1 		$4.43M Sell
763,096
-87,600
-10% -$521K 0.01% 1681
2021
Q4 		$6.38M Buy
850,696
+115,196
+16% +$1M 0.01% 1352
2021
Q3 		$6.63M Buy
735,500
+152,300
+26% +$1.51M 0.01% 1294
2021
Q2 		$6.98M Sell
583,200
-196,600
-25% -$2.23M 0.01% 1425
2021
Q1 		$9.77M Sell
779,800
-512,800
-40% -$6.91M 0.01% 1213
2020
Q4 		$20.2M Sell
1,292,600
-32,891
-2% -$385K 0.02% 754
2020
Q3 		$12.5M Buy
+1,325,491
New +$14.3M 0.01% 1004
2019
Q4 		– Sell
-67,000
Closed -$606K – 3718
2019
Q3 		$606K Sell
67,000
-559,800
-89% -$6.28M ﹤0.01% 2801
2019
Q2 		$6.75M Sell
626,800
-278,400
-31% -$2.96M 0.01% 1646
2019
Q1 		$8.64M Buy
+905,200
New +$9.25M 0.01% 1462
2018
Q1 		– Sell
-23,800
Closed -$390K – 3551
2017
Q4 		$390K Buy
+23,800
New +$354K ﹤0.01% 2942
2017
Q1 		– Sell
-321,819
Closed -$982K – 3389
2016
Q4 		$982K Sell
321,819
-272,681
-46% -$993K ﹤0.01% 2543
2016
Q3 		$2.75M Buy
594,500
+480,300
+421% +$2.44M ﹤0.01% 2003
2016
Q2 		$661K Sell
114,200
-389,864
-77% -$2.48M ﹤0.01% 2695
2016
Q1 		$3.05M Buy
504,064
+294,664
+141% +$1.77M 0.01% 1964
2015
Q4 		$1.91M Sell
209,400
-276,952
-57% -$2.13M ﹤0.01% 2142
2015
Q3 		$2.74M Buy
486,352
+378,655
+352% +$3.12M 0.01% 1788
2015
Q2 		$1.19M Buy
+107,697
New +$1.39M ﹤0.01% 2356
2013
Q3 		– Sell
-17,000
Closed -$133K – 2937
2013
Q2 		$133K Buy
+17,000
New +$148K ﹤0.01% 2591

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Renaissance Technologies's SGMO Position: Q1 2026 in Review

Renaissance Technologies reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 54% in Q1 2026, selling an estimated $1.83M and leaving 3,836,665 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

Renaissance Technologies first reported a position in SGMO in Q2 2013 and has held it in 35 quarters since. The position peaked at $20.2M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Renaissance Technologies held 3,836,665 shares of SANGAMO THERAPEUTICS INC worth $947K as of Q1 2026.
  • Renaissance Technologies sold 4,593,658 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $1.83M.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2302 holding.
  • Renaissance Technologies first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 35 quarters since.
  • Renaissance Technologies's SANGAMO THERAPEUTICS INC position peaked at $20.2M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.